Kaempferol also decreases iNOS, COX-2 and IL-18 production through inhibiting NF-κB, p38 phosphorylation and NLRP3 inflammasome activation in the SN from PD rats induced by 6-hydroxydopamine (6-OHDA) (53). Here, NFKB1 is linked to Parkinson disease.